Page 15/22
![]() Mycobacterium tuberculosis (purple) in the lung |
|
Option 1 suffers from problems that the control patients may not be good matches for severity of disease and the historic treatment might have been so bad that anything would be better (remember bloodletting for fever).
Option 2 suffers from the problem that the doctors can bias the trial by controlling when they enter the patients. The most sick then get the new wonder drug so you do not have a good control group.
The MRC choose to do two trials: